An Integrated Three-Product Herbal Strategy for Chronic Hepatitis B
Antiviral Control, Immune Modulation, Serological Stability, and Long-Term Liver Protection
Developed by Giddugala Yaala Aadaa Oromiyaa
Introduction
Chronic Hepatitis B is a persistent viral liver condition involving active HBV replication, long-term viral persistence, altered antiviral immune responses, and progressive stress on liver cells. Effective management therefore requires a coordinated approach that addresses not only circulating viral activity but also immune balance, serological stability, hepatocyte protection, and long-term preservation of liver function.
The Three-Product Chronic Hepatitis B Support Programme developed by Giddugala Yaala Aadaa Oromiyaa consists of three specialized herbal powder formulations: HepatoCure-B™, Seroconvert-B™, and HepaGuard-SVR™. Each product has a distinct therapeutic focus while functioning as part of one integrated system for virological control, immune modulation, serological maintenance, and long-term liver protection.
HepatoCure-B™ is the primary herbal antiviral component of the programme. It is formulated from selected medicinal plants with antiviral properties and is designed to support suppression of HBV replication, assist in achieving and maintaining HBV DNA negativity, and promote normalization of important liver-function parameters, including ALT, AST, and bilirubin. It also supports hepatocellular protection and immune-mediated control of viral activity.
Seroconvert-B™ is the immune-modulation and serological-stability component. It is designed to enhance cell-mediated antiviral immune responses, support balanced immune activity, assist in maintaining HBsAg negativity, and promote sustained Anti-HBs positivity. By strengthening immune surveillance, it also supports long-term serological stability and helps reduce the risk of renewed viral activity.
HepaGuard-SVR™ is the liver-protection and long-term stability component of the programme. It is formulated to support maintenance of sustained virological response, protect hepatocytes from functional deterioration, strengthen antioxidant defence, and maintain normal liver-enzyme levels. Its role is to preserve long-term immune, metabolic, biochemical, and functional liver stability following improvement in virological and serological parameters.
Scientific Structure of the Programme
The scientific structure of this programme is based on three interconnected priorities:
Suppression and long-term control of HBV replication
Restoration and maintenance of effective immune and serological stability
Protection of hepatocytes and preservation of long-term liver function
The three formulations are designed to complement one another within a coordinated therapeutic pathway.
HepatoCure-B™ focuses on active antiviral and virological control.
Seroconvert-B™ supports immune-mediated control and stable serological outcomes.
HepaGuard-SVR™ protects the liver and helps maintain the improvements achieved during the earlier stages of management.
Principal Objectives of the Programme
The principal objectives of the programme include:
Supporting suppression of HBV replication
Assisting in achieving and maintaining HBV DNA negativity
Supporting normalization of ALT, AST, and bilirubin balance
Enhancing cell-mediated antiviral immune responses
Supporting maintenance of HBsAg negativity
Promoting sustained Anti-HBs positivity
Reducing the risk of viral reactivation
Protecting hepatocytes from inflammatory, oxidative, and metabolic stress
Supporting normal liver-enzyme levels
Maintaining sustained virological, immune, metabolic, and liver stability
The purpose of this scientific presentation is to explain the individual and integrated roles of Seroconvert-B™, HepatoCure-B™, and HepaGuard-SVR™.
Together, these three products form a structured herbal programme designed to move from active viral control to immune and serological stability, followed by long-term hepatocyte protection and preservation of healthy liver function.
Developed by Giddugala Yaala Aadaa Oromiyaa, this integrated programme combines herbal antiviral activity, immune modulation, serological support, hepatocellular protection, antioxidant support, and long-term liver maintenance within one coordinated Chronic Hepatitis B support system.
The Three-Product Chronic Hepatitis B Support Programme is a professionally structured herbal product system developed by Giddugala Yaala Aadaa Oromiyaa.
The programme combines immune modulation, antiviral support, serological stability, hepatocellular protection, and long-term liver maintenance. Each product has a distinct therapeutic purpose and may be used according to the individual’s clinical condition, laboratory findings, treatment stage, and professional healthcare direction.
Seroconvert-B™
Immune-Modulating Herbal Powder
Developed by Giddugala Yaala Aadaa Oromiyaa
Product Overview
Seroconvert-B™ is a clinically oriented immune-modulating herbal powder developed to support immune regulation and long-term serological stability in individuals with Chronic Hepatitis B.
The formulation is designed to enhance the body’s cell-mediated antiviral immune response, support balanced immune activity, and assist the immune system in maintaining effective control of Hepatitis B Virus.
Seroconvert-B™ focuses particularly on supporting the maintenance of HBsAg negativity, sustained Anti-HBs positivity, and stable immune surveillance following improvement in serological and virological parameters.
The product is formulated to promote long-term immune balance while reducing the possibility of viral reactivation and loss of previously achieved serological stability.
Intended Mechanistic Focus
Seroconvert-B™ is designed to support several coordinated immune and serological mechanisms, including:
Modulation of the immune response against Hepatitis B Virus
Enhancement of cell-mediated antiviral immunity
Support for effective immune recognition of HBV-infected hepatocytes
Maintenance of balanced immune activation
Support for long-term serological stability
Assistance in maintaining HBsAg negativity
Support for sustained Anti-HBs antibody positivity
Strengthening of immune surveillance against residual viral activity
Reduction of factors associated with viral reactivation
Support for long-term immune-mediated control of HBV
Therapeutic Purpose
Support immune-mediated control of HBV
Assist in maintaining HBsAg negativity
Support sustained Anti-HBs positivity
Key Intended Benefits
Enhanced Cell-Mediated Immune Response
Supports the activity of immune cells involved in recognizing and controlling Hepatitis B Virus and HBV-infected hepatocytes.
Immune Modulation
Promotes a coordinated antiviral immune response while supporting appropriate immune balance.
Serological Stability
Supports the maintenance of stable Hepatitis B serological parameters following improvement or seroconversion.
Maintenance of HBsAg Negativity
Assists the immune system in maintaining the absence of detectable Hepatitis B surface antigen.
Support for Anti-HBs Positivity
Supports the maintenance of Anti-HBs antibodies associated with long-term immune protection and serological stability.
Reduction of Viral Reactivation Risk
Supports sustained immune surveillance and reduces factors that may contribute to renewed viral activity.
Long-Term Immune Support
Promotes continued immune-mediated control of HBV and supports lasting serological stability.
Primary Goal
To strengthen immune-mediated control of Hepatitis B Virus, support the maintenance of HBsAg negativity, sustain Anti-HBs positivity, preserve serological stability, and reduce the risk of viral reactivation.
Directions for Use
Dissolve one sachet in lukewarm water once daily, preferably in the morning.
Role Within the Product Programme
Seroconvert-B™ serves as the immune-modulation and serological-stability component of the programme.
It is designed to strengthen long-term antiviral immune control, support stable serological outcomes, and help maintain the immune and antibody responses achieved during the management of Chronic Hepatitis B.
HepatoCure-B™
Herbal Antiviral Powder
Developed by Giddugala Yaala Aadaa Oromiyaa
Product Overview
HepatoCure-B™ is a standardized herbal antiviral powder formulated from selected medicinal plants with antiviral properties and developed to support virological control in individuals with Chronic Hepatitis B.
The formulation is designed to suppress Hepatitis B Virus replication, support reduction of circulating viral activity, and assist in achieving and maintaining HBV DNA negativity.
HepatoCure-B™ also provides hepatocellular support by helping protect liver cells from viral, inflammatory, and metabolic injury. It supports the normalization of important liver-function parameters, including ALT, AST, and bilirubin levels.
The product combines antiviral support, hepatocyte protection, liver-function support, and immune-mediated viral control within one coordinated herbal formulation.
Intended Mechanistic Focus
HepatoCure-B™ is designed to support several complementary antiviral and hepatocellular mechanisms, including:
Suppression of active HBV replication
Reduction of circulating HBV DNA levels
Support for achieving HBV DNA negativity
Maintenance of long-term virological control
Reduction of viral activity within liver hepatocytes
Protection of hepatocytes from viral and inflammatory injury
Support for stabilization of hepatocellular function
Improvement of ALT and AST balance
Support for normal bilirubin metabolism
Strengthening of immune-mediated viral control
Support for restoration of normal liver-function parameters
Prevention of continued viral and inflammatory liver damage
Therapeutic Purpose
Support suppression of HBV replication
Assist in achieving and maintaining HBV DNA negativity
Support normalization of liver-function parameters
Key Intended Benefits
Antiviral Activity Against Hepatitis B Virus
Supports suppression of HBV replication and helps reduce viral activity in the blood and liver.
HBV DNA Reduction
Assists in the progressive reduction of HBV DNA levels and supports the achievement and maintenance of HBV DNA negativity.
Virological Control
Supports sustained control of viral replication and reduces the possibility of continuing viral damage to liver tissue.
Hepatocellular Support
Supports the normal structure, function, and metabolic activity of hepatocytes during Chronic Hepatitis B management.
Hepatocyte Protection
Helps protect liver cells from viral injury, inflammation, oxidative stress, and immune-mediated damage.
Improvement of ALT and AST Balance
Supports normalization of aminotransferase levels associated with hepatocellular inflammation and injury.
Bilirubin Balance
Supports healthy bilirubin processing, metabolism, and elimination by the liver.
Immune-Mediated Viral Control
Supports the immune system’s ability to recognize and control HBV activity.
Liver-Function Support
Promotes stable liver metabolism, detoxification, protein synthesis, and other essential hepatic functions.
Primary Goal
To suppress HBV replication, assist in achieving and maintaining HBV DNA negativity, protect hepatocytes, support normalization of ALT, AST, and bilirubin levels, and strengthen immune-mediated control of Hepatitis B Virus.
Directions for Use
Dissolve one sachet in a glass of lukewarm water once daily after meals.
Role Within the Product Programme
HepatoCure-B™ serves as the primary antiviral and virological-control component of the programme.
It focuses on reducing HBV replication, supporting HBV DNA negativity, protecting hepatocytes, improving liver-function parameters, and strengthening the body’s immune-mediated response against the virus.
HepaGuard-SVR™
Liver Protection and Stability Herbal Powder
Developed by Giddugala Yaala Aadaa Oromiyaa
Product Overview
HepaGuard-SVR™ is a protective herbal powder formulated to support long-term liver stability and maintain sustained virological response in individuals with Chronic Hepatitis B.
The formulation is designed to protect hepatocytes from functional deterioration, oxidative stress, chronic inflammation, and metabolic injury while supporting long-term liver health.
HepaGuard-SVR™ helps maintain stable liver-enzyme levels, supports antioxidant defence, promotes metabolic balance, and strengthens the long-term immune stability required to preserve virological control.
The product is intended as a long-term protective and maintenance formulation following improvement in viral, serological, and liver-function parameters.
Intended Mechanistic Focus
HepaGuard-SVR™ is designed to support long-term liver and virological stability through:
Maintenance of sustained virological response
Protection of hepatocytes from functional deterioration
Reduction of oxidative stress within liver tissue
Support for antioxidant defence mechanisms
Maintenance of normal liver-enzyme levels
Preservation of healthy hepatocyte structure and function
Support for stable liver metabolism
Strengthening of long-term immune stability
Maintenance of balanced metabolic activity
Reduction of factors associated with renewed liver injury
Support for long-term hepatic functional capacity
Preservation of liver health following virological improvement
Therapeutic Purpose
Support maintenance of sustained virological response
Protect hepatocytes from functional deterioration
Support long-term liver health
Key Intended Benefits
Hepatoprotective Support
Protects hepatocytes from chronic inflammatory, oxidative, metabolic, and functional stress.
Antioxidant Support
Supports the liver’s natural antioxidant defence systems and helps reduce oxidative damage to hepatocytes.
Maintenance of Sustained Virological Response
Supports the continued stability of virological improvements achieved during previous stages of treatment.
Normal Liver-Enzyme Support
Supports the maintenance of normal ALT, AST, and other important liver-function parameters.
Hepatocyte Stability
Helps preserve normal hepatocyte structure, metabolic activity, and functional capacity.
Long-Term Immune Stability
Supports balanced immune surveillance and long-term immune-mediated control of HBV.
Metabolic Stability
Promotes stable liver metabolism, energy regulation, protein synthesis, and detoxification.
Protection Against Functional Deterioration
Helps reduce factors that may contribute to progressive decline in liver-cell function.
Long-Term Liver Health
Supports continued liver protection, structural stability, and functional wellness over the long term.
Primary Goal
To maintain sustained virological response, protect hepatocytes from functional deterioration, preserve normal liver-enzyme levels, strengthen immune and metabolic stability, and support long-term liver health.
Directions for Use
Dissolve one sachet in water once daily, three to five times per week, or as directed by a healthcare professional.
Role Within the Product Programme
HepaGuard-SVR™ serves as the long-term liver-protection, stability, and maintenance component of the programme.
It is designed to preserve previously achieved virological and liver-function improvements, maintain healthy hepatocyte activity, support immune and metabolic balance, and promote long-term liver stability.
Programme Summary
Seroconvert-B™
Primary Focus
Immune modulation, enhancement of cell-mediated antiviral response, maintenance of HBsAg negativity, sustained Anti-HBs positivity, serological stability, and reduction of viral reactivation risk.
HepatoCure-B™
Primary Focus
Suppression of HBV replication, achievement and maintenance of HBV DNA negativity, hepatocyte protection, normalization of ALT, AST, and bilirubin levels, and immune-mediated viral control.
HepaGuard-SVR™
Primary Focus
Maintenance of sustained virological response, long-term hepatocyte protection, antioxidant support, stable liver-enzyme levels, and preservation of immune, metabolic, and functional liver stability.
Developed by Giddugala Yaala Aadaa Oromiyaa
The Seroconvert-B™, HepatoCure-B™, and HepaGuard-SVR™ product programme is developed by Giddugala Yaala Aadaa Oromiyaa as an integrated herbal support system for immune modulation, antiviral activity, virological control, serological stability, hepatocyte protection, liver-function support, and long-term liver health.